Does Paricalcitol (Zemplar®) interfere with 1,25-dihydroxyvitamin D measurement by liquid chromatography-tandem mass spectrometry assays?

Clin Chim Acta. 2013 Jan 16:415:230-2. doi: 10.1016/j.cca.2012.10.050. Epub 2012 Nov 7.
No abstract available

Publication types

  • Letter

MeSH terms

  • Artifacts*
  • Bone Density Conservation Agents / blood*
  • Bone Density Conservation Agents / pharmacokinetics
  • Bone Density Conservation Agents / therapeutic use
  • Chromatography, Liquid / standards
  • Ergocalciferols / blood*
  • Ergocalciferols / pharmacokinetics
  • Ergocalciferols / therapeutic use
  • Humans
  • Hyperparathyroidism, Secondary / prevention & control
  • Renal Insufficiency, Chronic / blood
  • Renal Insufficiency, Chronic / drug therapy
  • Renal Insufficiency, Chronic / pathology
  • Sensitivity and Specificity
  • Tandem Mass Spectrometry / standards
  • Vitamin D / analogs & derivatives*
  • Vitamin D / blood

Substances

  • Bone Density Conservation Agents
  • Ergocalciferols
  • Vitamin D
  • 1,25-dihydroxyvitamin D
  • paricalcitol